Home » Champions, Concordia Establish Royalty Agreement for Oncology Drug
Champions, Concordia Establish Royalty Agreement for Oncology Drug
Champions Biotechnology, Inc. announced that it has entered into a royalty agreement with Concordia Pharmaceuticals for the use of Salirasib, Concordia’s novel compound for the treatment of cancer, in combination with another targeted drug.
centredaily.com
centredaily.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May